Hyoscine butyl bromide

PreclinicalSmall molecule

WWoman's Health University Hospital, Egypt

Hyoscine butyl bromide is one of 2 small molecule programs targeting Celecoxib. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

CelecoxibCompleted

CelecoxibPreclinical

Completed

Competition

Competitive Landscape

1 competitor in Celecoxib

#DrugCompanyPhaseTrials

Celebrex

PPhiladelphia Eye Associates

Approved

31 2

Hyoscine butyl bromide

WWoman's Health University Hospital, Egypt

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Labor2 trials

The Effect of Hyoscine Butylbromide on Shortening of First and Second Stages of Labor

Completed·WWoman's Health University Hospital, Egypt·Phase 2·NCT02839213·400 enrolled

The Effect of Hyoscine Butyl Bromide on the First Stage of Labor in Term Pregnancies

Completed·UUniversity Hospital of the West Indies·Phase 2·NCT00409890·120 enrolled

Post Operative Pain1 trial

A Trial for Peroperative Procedure and Postoperative Pain After Rectal Misoprostol or Rectal Hyoscine Administration

Completed·—·N/A·NCT03359655·120 enrolled

Prolonged Labor1 trial

Hyoscine Butyl Bromide for Management of Prolonged Labor

Unknown status·—·Phase 3·NCT01854073·500 enrolled

Hysteroscopy1 trial

Oral Hyoscine Butyl Bromide Versus Diclofenac Potassium Before Office Hysteroscopy

Completed·—·Phase 2/3·NCT02714699·129 enrolled

Pain1 trial

Hyoscine Butyl Bromide in Reducing Pain During HSG

Completed·—·Phase 4·NCT02709603·200 enrolled

2 more indications

Celecoxib1 trial

Celecoxib Versus Hyoscine Butyl-bromide in Reducing Pain Associated With IUD.

Completed·—·N/A·NCT03499743·105 enrolled

Diclofenac1 trial

Oral Diclofenac Sodium Versus Oral Hyoscine Butyl Bromide During Intrauterine Device Insertion

Completed·—·Phase 4·NCT02714231·100 enrolled

Sources

References

[1]
ClinicalTrials.gov — 8 trial records for Hyoscine butyl bromide. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Hyoscine butyl bromide compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Hyoscine butyl bromide. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Woman's Health University Hospital, Egypt company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: WWoman's Health University Hospital, Egypt

Hyoscine butyl bromide

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Labor2 trials

Post Operative Pain1 trial

Prolonged Labor1 trial

Hysteroscopy1 trial

Pain1 trial

Celecoxib1 trial

Diclofenac1 trial

References

Drug Info

Quick Facts

Related News